Come up with a name for your new list and we'll add to it:
Universal Cells was acquired by
Astellas Pharma on February 14, 2018.
Universal Cells aims to provide customers with the tools they need to reliably and accurately edit the stem cell genome. The company's technology is based on AAV-mediated gene targeting, which offers …